Evaluating and treating eye diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The National Eye Institute (NEI) is conducting an observational study to evaluate and provide standard treatment for individuals with various eye diseases. Participants will undergo a series of eye exams and assessments over a period of up to five years, with visits ranging from one to twelve times per year based on their specific condition. The study aims to collect data and specimens to enhance understanding of eye diseases, their inheritance, and the effectiveness of standard treatments. Additionally, it seeks to establish a resource for future research on ocular conditions.

Why it matters

Who can join: the full rules

* INCLUSION CRITERIA:

To be eligible, the following inclusion criteria must be met, where applicable.

1. Have a diagnosed, undiagnosed or suspected eye disease.
2. Have the ability to understand and sign an informed consent or have a parent/legal guardian do so if they are minor children or a legally authorized representative (LAR) to provide consent for adults without consent capacity.

EXCLUSION CRITERIA:

A participant is not eligible if any of the following exclusion criteria are present.

1. Are unwilling to give informed consent or assent when applicable.
2. Are unwilling or unable to be followed as clinically indicated.
3. Have a systemic disease that compromises the ability of NEI clinicians to provide adequate ophthalmologic examination or treatment.

Where it's running

• National Institutes of Health Clinical Center
  Bethesda, Maryland, United States Recruiting

Study contacts

• Principal investigator: Awilda V Holland, R.N. — National Eye Institute (NEI)
• Study coordinator: Awilda V Holland, R.N.
• Email: aholland@nei.nih.gov
• Phone: (301) 435-1831

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Zamidine eye drops to prevent infections during eye surgery

  This study is testing if Zamidine eye drops can help prevent infections in patients having eye surgery by reducing harmful bacteria on the eye's surface.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT06771908

• VLCPUFA-rich fish oil and standard DHA oil: who reaches a higher omega-3 index?

  This study tests whether VLCPUFA-rich fish oil raises the blood omega-3 index more than a standard DHA-rich fish oil in healthy adults aged 18–60.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07882160

• Blood biomarkers for immune-related neuropsychiatric conditions

  This study tests whether blood biomarkers can help identify neuropsychiatric disorders that may be linked to the immune system in people of any age.

  Recruiting at 3 sites National Institutes of Health Clinical Center (CC) · Los Angeles, California and 2 other locations · NCT07877246

• First-in-human imaging of PDE4D with [11C]JMJ-129-d2 in healthy volunteers

  A new PET tracer called [11C]JMJ-129-d2 is being tested in healthy adults to see if it safely and reliably images the brain’s PDE4D enzyme and to measure how the tracer distributes in the body.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07853781

• Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people

  This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07829497

• Augmenting Parent Management Training with a Smartphone Tool

  This study tests whether adding a smartphone app to parent management training helps reduce irritability and temper outbursts in kids aged 8–13 with disruptive behavior disorders.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07764536

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.